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Wolbachia pipientis delays RNA virus-induced mortality inDrosophila spp. We investigated whetherWolbachia-mediated pro-
tection was dependent on the small interfering RNA (siRNA) pathway, a key antiviral defense. Compared toWolbachia-free flies,
virus-inducedmortality was delayed inWolbachia-infected flies with loss-of-function of siRNA pathway components, indicating
thatWolbachia-mediated protection functions in the absence of the canonical siRNA pathway.
Viruses, as obligate intracellular pathogens, rely on their hostsfor proliferation, and the interaction is therefore a balance
between the virus and the host. However, recently it has become
increasingly clear that in addition to the contributions of the host
and the parasite, othermicrobes within the host organism can also
affect the outcome of infection (reviewed in reference 3). An ex-
ample of this is the antiviral effect observed in insects, which is
mediated by infection with the endosymbiotic bacteriumWolba-
chia pipientis (8, 23).
The presence of Wolbachia protects Drosophila spp. from
virus-induced mortality (8, 21, 23). Wolbachia is an obligate in-
tracellular, Gram-negative bacterium that is maternally inherited
(reviewed in references 18, 22, and 26).Wolbachia is estimated to
infect up to 70% of all insect species as well as filarial nematodes
and crustacean and mite species (10, 12). Compared to Wolba-
chia-free flies, Drosophila melanogaster flies infected with Wolba-
chia have delayed virus-induced mortality when injected with di-
verse single-stranded RNA viruses, including the dicistroviruses
Drosophila C virus (DCV) and cricket paralysis virus (CrPV) or
the nodavirus Flock House virus (FHV) (8, 23). Wolbachia-in-
fected D. melanogaster flies also accumulated lower titers of DCV
and Nora virus than their Wolbachia-free counterparts (8, 23).
However, delayed virus-induced mortality can occur without de-
creased virus accumulation (21, 23). To date, Wolbachia-medi-
ated protection inD. melanogaster has only been observed against
RNA viruses. The presence of Wolbachia did not affect either ac-
cumulation of or mortality induced by the double-stranded DNA
(dsDNA) virus insect iridescent virus 6 (IIV-6) inD. melanogaster
(23).
The Wolbachia-mediated antiviral effect is not specific to D.
melanogaster. Similar antiviral protection is observed in Drosoph-
ila simulans as well as in mosquitoes (1, 15, 19, 21). Artificial
infection of Aedes aegypti with Wolbachia inhibits infection by
dengue virus and Chikungunya virus as well as the malaria para-
site Plasmodium gallinaceum, the bacterium Erwinia carotovora,
and filarial nematodes (1, 11, 14, 15, 19). While in the mosquito
Culex quinquefasciatus, natural Wolbachia infection has a minor
impact on West Nile virus (WNV) infection (7). Interestingly,
Wolbachia-infected Drosophila is not protected against infection
with pathogenic Gram-negative bacteria, including Erwinia caro-
tovora (27), indicating that the mechanism of antiviral protection
is independent of the mechanism of antibacterial protection. De-
spite being an increasingly observed phenomenon, the mecha-
nism by which Wolbachia infection mediates an antiviral effect
against RNA viruses is currently unknown.
In insects, RNA interference (RNAi) is a key host viral defense
pathway. Drosophila melanogaster has three major RNAi path-
ways: the siRNA pathway, which has been found to be important
for the control of virus infection; the microRNA (miRNA) path-
way, which primarily regulates host gene expression; and the Piwi-
associated RNA (piRNA) pathway, which is involved in control-
ling germ line mobile genetic elements (6). The siRNA pathway
inhibits viral replication by sequence-specific degradation of the
viral RNA. In Drosophila, double-stranded RNA (dsRNA) is first
recognized and digested by the RNase III enzyme Dicer-2 (Dcr-2)
into short interfering RNAs (siRNA) (6). Dicer-2 forms a het-
erodimer with a dsRNA-binding protein (dsRBP) called R2D2.
R2D2 is required for loading the siRNA into the RNA-induced
silencing complex (RISC). One siRNA strand is then used as a
template for Argonaute2 (AGO2) to cleave complementary, sin-
gle-stranded RNA (6). Drosophila lines with loss-of-function or
null mutations for some components of the siRNA pathway have
previously been shown to increase susceptibility to RNA virus
infections (5, 24, 25).
Since the siRNA pathway is a major antiviral defense of Dro-
sophila andWolbachia infection in Drosophila has been shown to
have a protective affect against RNA viruses, we investigated
whether the mechanism of Wolbachia-mediated protection was
reliant on the siRNA pathway.
To assess whether the siRNA pathway is required for Wolba-
chia-mediated protection we usedDrosophila strains with loss-of-
functionmutations in specific components involved in the siRNA
pathway. All fly lines were maintained on standard cornmeal diet
at a constant temperature of 25°Cwith a 12-h light/dark cycle. The
lines used were the w1118 positive-control line and the dcr-2L811fsX
(16), r2d21/CyO (Bloomington Stock Center, no. 8518) (17), and
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AGO2414 (20) siRNA mutant lines. To generate wMel-infected
balancer lines,wMel-infectedw1118 (28) femaleswere crossedwith
CyO/Gla or TM6B/TM3 Sbmales. wMel-infected CyO/ females
were crossed with wMel-infected Gla/ males to establish the
wMel-infected CyO/Gla line. wMel-infected TM6B/ females
were crossed withwMel-infectedTM3 Sb/males to establish the
wMel-infected TM6B/TM3 Sb line. To generate wMel-infected
siRNA mutants, females of wMel-infected balancer lines (CyO/
Gla or TM6B/TM3 Sb flies) were crossed with males of siRNA
mutants.wMel-infectedAGO2414 and dcr-2L811fsX flies weremain-
tained and used for experiments as homozygotes. The wMel-in-
fected r2d2 mutant was maintained and used in experiments as
heterozygotes balanced over the CyO chromosome due to high
mortality of homozygotes. All Wolbachia-infected fly lines were
treated with 0.03% tetracycline to cure the Wolbachia infection.
Following the tetracycline treatment, flies were held formore than
five generations to recover before the absence of Wolbachia was
confirmed by PCR, and then the flies were used for experiments.
All stocks were cleared of possible DCV contamination by bleach
treatment of eggs, as previously described (21).
The siRNA mutant lines, in the presence and absence of
Wolbachia infection, were injected with FHV, and their mortality
rates were compared (Fig. 1). For survival assays, the flies used
were male and 4 to 7 days old. Flies were anesthetized with carbon
dioxide, and 50.6 nl of virus or phosphate-buffered saline (PBS)
for controls was injected into the upper lateral part of the abdo-
men by using needles pulled fromborosilicate glass capillaries and
a Nanoject II microinjector. PBS was injected as a negative con-
trol. Virus samples prepared as previously described (9, 13) were
diluted in PBS, and approximately 100 infectious units (IU) of
DCV or 300 IU of FHVwas injected into each fly. For each fly line
assayed, three groups of 15 flies were injected with virus, one
group of 15 flies was injected with PBS, and mortality was re-
corded daily.Mortality that occurredwithin 1 day of injectionwas
deemed to be due to needlestick injury. Each experiment was then
repeated three times using independent cohorts of male flies and
once using female flies. The graphs shown represent results from a
single male fly experiment; similar results were observed across all
four experiments (data not shown). The data were analyzed using
the log-rank (Mantal-Cox) test on Kaplan-Meier survival curves
(GraphPad Prism 5).
Wolbachia-mediated delay of FHV-induced mortality was
present in the positive-control flies (w1118), as has previously been
shown (8, 23). Likewise in the presence of Wolbachia, mortality
was delayed in flies from the three siRNA mutant lines compared
toWolbachia-free flies from the same lines (Fig. 1). The continu-
ing presence ofWolbachia-mediated protection in all siRNA mu-
tants indicated thatWolbachia-mediated protection can function
in the absence of the canonical siRNA pathway.
Antiviral protectionmediated byWolbachia inD.melanogaster
has previously been shown for a number of RNA viruses, includ-
ing DCV (8, 23). To confirm thatWolbachia-mediated protection
is independent of the host’s siRNA pathway in general, not just in
the case of FHV infection, mortality assays of DCV-infected
siRNA mutants, with and without Wolbachia, were undertaken
(Fig. 2). For the w1118 line and both the r2d2 and AGO2 mutant
FIG1 Effect of the presence (wol) or absence (wol) ofWolbachia on FHV-inducedmortality in flies from thew1118 control line (A) and theDicer-2L811fsX (B),
r2d21/Cyo (C), and AGO2414 (D) mutant lines. Adult flies 4 to 7 days old were injected with PBS as a negative control, or FHV, and their mortality was assayed.
Wolbachia-mediated protection against FHV-induced mortality was statistically significant in w1118 flies and the siRNA mutants (P  0.0001, P 0.0001,
P0.0001, and P 0.001, respectively). Bars indicate standard errors. Each experiment was repeated in triplicate, and representative graphs are shown.
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lines, mortality in Wolbachia-infected flies was delayed in com-
parison to that in paired Wolbachia-free flies, indicating that
Wolbachia was mediating antiviral protection in these flies. The
experiments presented do not exclude an auxiliary role for siRNA
in Wolbachia-mediated protection; however, they indicate that
Wolbachia-mediated protection against RNAviruses is not depen-
dent on the canonical siRNA pathway in Drosophila. These find-
ings are consistent with previous studies that showed thatWolba-
chia inhibits dengue virus replication in the A. albopictus-derived
C6/36 cell line, which has a disfunctional antiviral RNA interfer-
ence pathway (2, 4), andAGO-2mutant flies are more resistant to
WNV infection when infected withWolbachia (7).
There aremany other possiblemechanisms forWolbachia-me-
diated protection, including competition for cellular components
or upregulation of other immune pathways. There is some evi-
dence for the involvement of immune genes in mosquitoes (1, 15,
19). Unlike in the artificially infected mosquitoes,Drosophila flies
with naturalWolbachia infection are not protected against bacte-
rial infection, and there is no upregulation of the Imd or Toll
immune pathways (27). There may be differences in Wolbachia-
host interactions between recently introduced Wolbachia infec-
tions and those where the host andWolbachia have been evolving
together for some time. In addition there are likely to be different
mechanisms behind Wolbachia-mediated protection against vi-
ruses, bacteria, and eukaryotic protists.
This study investigated whether Wolbachia-mediated protec-
tion against viruses is dependent on the siRNA pathway, a key
antiviral response in Drosophila and other insects. The results
demonstrate that the canonical siRNA pathway is not essential for
Wolbachia-mediated protection.
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